Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,450.00
-280.00 (-3.21%)
Last updated: Apr 9, 2026, 1:41 PM KST
Market Cap241.63B +169.4%
Revenue (ttm)108.14B +5.8%
Net Income1.41B
EPS60.34
Shares Out27.68M
PE Ratio144.69
Forward PEn/a
Dividend30.00 (0.36%)
Ex-Dividend DateMar 3, 2026
Volume201,446
Average Volume430,383
Open8,660.00
Previous Close8,730.00
Day's Range8,420.00 - 8,660.00
52-Week Range2,995.00 - 15,960.00
Beta0.96
RSI42.18
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements